Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444184
Status:
COMPLETED
Last Update Posted:
2014-05-12
First Post:
2007-03-05
Brief Title:
24-hour Intraocular Pressure Control With TravoprostTimolol Fixed Combination Versus Travoprost
Sponsor:
Aristotle University Of Thessaloniki
Organization:
Aristotle University Of Thessaloniki
Study Overview
Official Title:
A Crossover Double-Masked Comparison Investigating the 24-Hour Intraocular Pressure Control With the TravoprostTimolol Fixed Combination Versus Travoprost When Both Are Given in the Evening in Subjects With Primary Open-Angle Glaucoma
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This 8-week crossover study will compare the quality of 24-hour IOP control with TTFC versus travoprost when both medications are dosed in the evening Such a crossover comparison may determine the real efficacy of the new fixed combination versus travoprost monotherapy The results should enhance the investigators understanding on the best dosing of TTFC and may influence its clinical use in Europe Finally the results would better delineate the future role of TTFC in glaucoma management after PG monotherapy or instead of unfixed therapy with PG analogs and timolol This study should assist the general ophthalmologist worldwide to plan optimal stepwise medical therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None